MoneyWorks4Me

Medicamen Biotech informs about board meeting

06 Nov 2020 Evaluate

Medicamen Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020, to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the half year ended on September 30, 2020.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..